Peter Switzer speaks to the founder and CEO of Oventus (OVN), Dr Chris Hart.

If we learned something from 2020 it’s that you underestimate our ability to think and achieve outside the square at your peril. So get your passport ready!

On this week's show, Peter Switzer is joined by Fairmont Equities' Michael Gable, Burman Invest's Julia Lee, Switzer's Paul Rickard and Avecho's Dr Paul Gavin.

Unless we can conquer the increasing scourge of antibiotic resistance, we’ll enter the post antibiotic era — a much scarier thought than our current COVID-19 pandemic.

While shares are at risk of a short-term correction, improving global growth, more stimulus, vaccines and low interest rates augur well for growth assets this year.

Peter Switzer is joined by Brian Ward, the founder and CEO of soft tissue regeneration company Aroa (ARX).

If you’re like me and think there are good times ahead, let’s focus on making money this year!

Share markets down, Aussie dollar on the up, vaccinations kick off and more!

Dr Ross Walker explains two studies that are finding new treatments for Glioblastoma, one of the most devastating kinds of brain tumour.